Hyperbaric Novabupi® in Spinal Anesthesia in Lower Limbs Vascular Surgery
Status:
Not yet recruiting
Trial end date:
2022-11-30
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, active-controlled study to evaluate the
non-inferiority of hyperbaric Novabupi® versus hyperbaric Neocaine® in spinal anesthesia in
lower limbs vascular surgery.
The schedule consists of four visits: screening (visit 1); pre-anesthetic evaluation and
randomization (visit 2); treatment (visit 3) and discharge from study (visit 4).